156 related articles for article (PubMed ID: 37633416)
1. Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition.
Kabil SL; Rashed HE; Mohamed NM; Elwany NE
Life Sci; 2023 Oct; 331():122037. PubMed ID: 37633416
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
5. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
6. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
[TBL] [Abstract][Full Text] [Related]
7. PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3β/β-Catenin Signaling Pathway in Human Gastric Cancer.
Ma J; Guo X; Zhang J; Wu D; Hu X; Li J; Lan Q; Liu Y; Dong W
Dig Dis Sci; 2017 Dec; 62(12):3415-3425. PubMed ID: 29030742
[TBL] [Abstract][Full Text] [Related]
8. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
9. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
[TBL] [Abstract][Full Text] [Related]
10. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
11. Diminished membrane recruitment of Akt is instrumental in alcohol-associated osteopenia via the PTEN/Akt/GSK-3β/β-catenin axis.
Chen YX; Zhu DY; Gao J; Xu ZL; Tao SC; Yin WJ; Zhang YL; Gao YS; Zhang CQ
FEBS J; 2019 Mar; 286(6):1101-1119. PubMed ID: 30656849
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
[TBL] [Abstract][Full Text] [Related]
13. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
[TBL] [Abstract][Full Text] [Related]
16. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
[TBL] [Abstract][Full Text] [Related]
17. Emodin Reverses the Epithelial-Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway.
Zheng Q; Wang J; Li W; Chen X; Chen S; Chen L
Drug Des Devel Ther; 2020; 14():3663-3672. PubMed ID: 32982173
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
[TBL] [Abstract][Full Text] [Related]
19. GSK3β attenuates TGF-β1 induced epithelial-mesenchymal transition and metabolic alterations in ARPE-19 cells.
Huang L; Zhang C; Su L; Song Z
Biochem Biophys Res Commun; 2017 May; 486(3):744-751. PubMed ID: 28342867
[TBL] [Abstract][Full Text] [Related]
20. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
Hu C; Dong T; Li R; Lu J; Wei X; Liu P
Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
